Clinical trial
Prevail Global Study
NCT06535854 · Medtronic Vascular, Industry · Recruiting
Key facts
| NCT number | NCT06535854 |
|---|---|
| Title | Prevail Global Study |
| Official title | A Randomized Controlled Study of the Prevail Drug-Coated Balloon in Subjects With In-stent Restenosis and a Single Arm Prospectively Enrolled Study of the Prevail Drug-Coated Balloon for de Novo Lesions in Small Vessel Disease (Prevail Global). |
| Lead sponsor | Medtronic Vascular, Industry |
| Status | Recruiting |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | Prevail DCB, Agent DCB |
| Enrollment | 1,205 |
| Start date | Feb 24, 2025 |
| Primary completion | Feb 1, 2027 |
| Completion | Feb 1, 2031 |
| First posted | Aug 2, 2024 |
| Last update posted | Oct 24, 2025 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- 10–99 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: